news.cision.com

The so-called toothbrush king, also founder of The Humble Co., Noel Abdayem, who has been a shareholder in Dentalum for some time, is now taking a seat in the company's investment committee.Noel Abdayem is a dentist as well as a successful entrepreneur. In 2013, parallel to his dental studies in Riga, Latvia, Noel started The Humble Co. that initially produced an environmentally friendly bamboo toothbrush. The Humble Co. grew to become a powerful distribution company and is today the leading FMCG group in health and wellness. Noel has been awarded “Årets Raket” within YEoS - Sweden's

Reducing water loss in piping systems

How can water resources be conserved? How do we need to change managing water and sanitation services? The Asian Development Bank (ADB) invited Sanjay Patel from GF Piping Systems (GF), to speak about how pressure management technology and digitization of utility networks can be a solution to water losses at their e-Marketplace for Water-Secure and Resilient Asia and Pacific, on 26 October, 9 a.m CEST/ 3 p.m. Manila time.From 18-27 October the Asian Development Bank (ADB), as a promoter of social and economic development in Asia, hosts an e-Marketplace for a "Water-Secure and Resilient Asia

Anora announces future operating model

Anora Group Plc Stock Exchange Release 15 October 2021 at 10.00 am EET Anora announces future operating model Anora announces today its future operating model following the completion of the merger on 1 September 2021. The operating model will enable Anora to build on its strong platform in the Nordics, expand to international markets and drive productivity. Anora’s operating model caters to the different business dynamics across business areas and as of 1 January 2022, Anora’s four business areas will be: Wine, Spirits, International and Anora Industrial. The Wine business

New facility in Europe moves Pricer’s production closer to customers

As demand for in-store digitalization and solutions based on electronic shelf labels (ESL) is increasing, Pricer aims at meeting this expected continued higher volume demand with a new production facility in Europe, closer to its customers on this major market. Working in close collaboration to understand the customers’ long-term goals and their unique challenges, Pricer will be able to offer reduced lead-times and increased flexibility.To maintain the highest product quality, Pricer has engaged with Zollner, a global electronics manufacturing services (EMS) provider based in Germany, to

Recycled raw material shortages result in production curtailments at Metsä Tissue’s Mariestad mill – fresh fibre production continues normally

Fri, Oct 15, 2021 08:55 CET

The Covid-19 pandemic has accelerated the availability and quality challenges in recycled raw material for tissue production. This has resulted in temporary curtailments of the recycled paper production at Metsä Tissue’s Mariestad mill in Sweden. As a result of this, the fresh fibre portfolios will be prioritized in Metsä Tissue production and no wider delivery issues or tissue paper shortages are to be expected to end users, as fresh fibre raw material has a good and consistent availability.Similar recycled material availability issues for tissue production are being experienced throughout

Talkpool consolidates its IoT companies Talkpool AB and Home Solutions

The shareholders in Talkpool AB have agreed to accept an offer from Nordic Proptech Investment Services AB/Home Solutions (NPTIS) to acquire 100% of the shares in Talkpool AB. The shares will be paid with newly emitted NPTIS shares. Talkpool AG, the mother company of the international technology group Talkpool and majority owner of both Talkpool AB and NPTIS, will hold 51,9% of the new Swedish IoT company specialized in Smart Buildings. 48,1% will be held by Talkpool’s current co-owner Sacculus, together with the existing shareholders in Talkpool AB. Talkpool AB contributes with

QUARTERLY REPORT, THIRD QUARTER 2021

Fri, Oct 15, 2021 08:45 CET

Press release: Stockholm, October 15, 2021, 08.45 CET HIGHLIGHTS OF THE THIRD QUARTER 2021 · Net sales was 83 MSEK (130) · EBITDA was 13 MSEK (58) · EBIT was -9 MSEK (40) · Earnings per share was -0,07 SEK (0.18) · Operative cashflow in Q3 was 14 (22) MSEK and cash and cash equivalents were 48 MSEK (30) · Investments were 10 MSEK (4) · The production was about 308 000 (433 000) ounces silver, 839 (923) ounces gold, 323 (419) tonnes lead, and 742 (818) tonnes zinc in concentrates · Costs, i.e., supplies and other expenses, were 59 MSEK which was

BioStock: Chordate Medical’s CEO on US marketing plans

Fri, Oct 15, 2021 08:40 CET

Chordate Medical is initiating a pre-study in the US as a first step in obtaining market authorisation from the FDA for its migraine treatment. The pre-study is expected to be completed in Q1 2021 and will provide clarity as to which pathway is appropriate to achieve market approval in the US. BioStock contacted CEO Anders Weilandt to learn more about the process leading up to FDA approval and the possibilities in the US for the company’s migraine treatment.Read the full interview with CEO Anders Weilandt at biostock.se: https://www.biostock.se/en/2021/10/chordate-medicals-ceo-on-us-

Ford Honors Veoneer at 23rd Annual World Excellence Awards

· Veoneer has been honored by Ford Motor Company with a Create Must-Have Products World Excellence Award · Ford’s World Excellence Awards recognize companies that exceed expectations and achieve the highest levels of excellence in quality, cost, performance and delivery · Award categories include Treat Customers Like Family, Turn Around Automotive Operations and Compete Like a Challenger, Create Must-Have Products, Sustainability, Diversity and Inclusion, plus Gold and Silver Quality awards Stockholm, Sweden, October 15, 2021: The automotive technology company Veoneer, Inc. (

Epiroc wins large equipment order for greenfield mine in Canada

Stockholm, Sweden: Epiroc, a leading productivity and sustainability partner for the mining and infrastructure industries, has won a large order for surface mining equipment from IAMGOLD Corp. in Canada that will optimize safety and productivity through advanced automation. The machines will be used in production at a greenfield gold mine currently under construction.IAMGOLD has ordered several Pit Viper 231 and SmartROC D65 drill rigs for use at Côté Gold in Ontario, Canada, an open pit gold mine that is currently under construction and expected to start production in the second half of

Implantica announces initial UK surgical training for RefluxStop™

Implantica AG (publ) today announces that surgeons from three prominent reflux centers in the UK have completed RefluxStop™ training.“We are pleased to move forward in the UK after an extended break due to COVID-19. UK is an important market for RefluxStop™ where the device is reimbursed also in public healthcare (NHS). There are more than 4.6 million daily acid reflux sufferers in the UK, with around 400’000 patients annually diagnosed with acid reflux after staying overnight at a hospital and performing a diagnostic endoscopic procedure. We look forward to commencing surgeries in the near-

IRRAS Accounces Participation and Data Presentations at Two Upcoming, In-Person Neurosurgery Conferences

Stockholm, October 15, 2021 - IRRAS, a global medical technology company with a comprehensive portfolio of innovative products for neurocritical care, today announced that it will be participating in-person at the Congress of Neurological Surgeons’ annual meeting (CNS 2021), in Austin, TX, on October 16-20, 2021, as well as the Neurocritical Care Society’s annual meeting (NCS 2021), in Chicago, IL, on October 26-29, 2021. In addition, at CNS 2021, clinical data regarding the use of its IRRAflow system in the treatment of intracerebral hemorrhage (ICH) and intraventricular hemorrhage (IVH)

Invitation to presentation of Bravida’s sustainability strategy

Bravida's sustainability strategy will be presented by President and CEO Mattias Johansson at 10.30 on 26 October 2021.The presentation will be held in English and can be followed on the web or on the phone. There will be room for questions in the telephone conference. Link to webcasthttps://tv.streamfabriken.com/bravida-q3-2021Telephone conference dial-in numberSE: +46856642704 (Lokalt tel.nr) UK: +443333009263 (Lokalt tel.nr)US: +1 6319131422 (Lokalt tel.nr PIN: 1345 1744#) The presentation will be available on www.bravida.se/en/investorsFor further information,

BEWI – Shareholders representing the remaining 50 per cent of shares in Jackon accept the offer

With reference to the stock exchange notice issued by BEWI ASA ("BEWI" or the "Company") on 1 October 2021 regarding its offer to acquire all shares in Jackon Holding ("Jackon") and the announcement on 3 October 2021 regarding the acceptance received for 50 per cent of the shares in Jackon, BEWI now announces that the Company has received acceptances of the offer from shareholders holding the remaining 50 per cent of the shares in Jackon. All shareholders in Jackon have accordingly accepted the offer and share purchase agreements have been entered into between the parties. The Jackon

New US patent approval for Episurf Medical

Fri, Oct 15, 2021 08:22 CET

Episurf Medical (NASDAQ: EPIS B) has received another Notice of Allowance from the United States Patent and Trademark Office (USPTO). The patent, entitled “Determination and visualization of damage to an anatomical joint”, relates to 3D-based assessment of joint lesions, and complements Episurf Medical’s earlier US patents within this field. “With this we get additional IP protection in the US within the important and exciting field of medical imaging and surgical pre-planning. This constitutes an essential part of the company’s Episealer® implant technology” comments Katarina Flodström,

BioStock: Respiratorius begins production of VAL001

Respiratorius’ two development projects are running at full speed and a new formulation has been developed for the candidate VAL001. This paves the way for the next step and the company is now starting production for a phase I pharmacokinetic study with the new formulation. BioStock contacted the company’s CEO Johan Drott to find out more.Read the full article at biostock.se:https://www.biostock.se/en/2021/10/respiratorius-begins-production-of-val001/This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se

Imfinzi & tremelimumab improved OS in liver cancer

Fri, Oct 15, 2021 08:01 CET

15 October 2021 7:00 BST Imfinzi plus tremelimumab significantly improved overall survival in HIMALAYA Phase III trial in 1st-line unresectable liver cancer Trial met primary endpoint of overall survival with a single priming dose of tremelimumab plus Imfinzi every four weeks vs. sorafenib Imfinzi monotherapy met the overall survival endpoint of non-inferiority vs. sorafenib Positive high-level results from the HIMALAYA Phase III trial showed a single, high priming dose of tremelimumab added to Imfinzi (durvalumab) demonstrated a statistically significant and clinically

Invitation to conference call with web presentation of AcadeMedia's quarterly report for July - September 2021/22

AcadeMedia's quarterly report for July - September 2021/22 will be published at 08:00 CEST on 29 October. A web-cast telephone conference will be held at 09:30 CEST the same day, where CEO Marcus Strömberg and CFO Katarina Wilson will present the report. The presentation will be held in English and can be followed on the web or over the phone. It will be followed by a Q&A session. To participate in the conference call, and thereby be able to ask questions, call one of the following numbers ten minutes before the start of the call:SE: +46 8 5055 8374UK: +44 33 3300 9030US: +1 646

Invitation to conference call with web presentation of Cloetta AB´s interim report Q3 2021

Cloetta AB will publish the interim report for the period 1 July – 30 September 2021 on Friday 29 October 2021 at 08.00 a.m. CEST. Following this report Cloetta will organize a conference call with web presentation for media and the financial community.President and CEO Henri de Sauvage Nolting and CFO Frans Rydén will present and comment on the report. After the presentation there will be time for questions, both on the phone and in the web presentation. Time for the publication of the interim reportFriday 29 October at 08:00 a.m. CEST Time for conference call and web presentation

Metso Outotec to deliver modular cobalt solvent extraction technology to Canada

Metso Outotec Corporation’s press release on October 15, 2021, at 09:00 a.m. EESTMetso Outotec has signed an agreement with the Canadian battery materials company First Cobalt Corporation to deliver Planet Positive solvent extraction technology to their cobalt refinery expansion in Ontario. The value of the order is approximately EUR 10 million, and it has been booked into Metals’ Q4/2021 orders received. Metso Outotec’s scope of delivery includes the engineering and supply of a modular VSF®X solvent extraction

Nomination Committee appointed ahead of Collector’s AGM 2022

Collector AB (publ)’s Annual General Meeting will be held on Wednesday 4 May 2022. It is hereby announced that the company’s largest shareholders have appointed a Nomination Committee.The Nomination Committee has, ahead of the Annual General Meeting 2022, the following composition: · Sharam Rahi, appointed by Fastighets AB Balder, · Anna-Maria Lundström, appointed by StrategiQ Capital AB, · Jesper Mårtensson, appointed by Förvaltnings AB Färgax, and · Erik Selin, Chairman of the Board of Collector AB (publ) Sharam Rahi has been appointed Chairman of the Nomination Committee.

OKEA third quarter 2021 trading update